The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53
Abstract
Drug resistance in human cancer is associated with overexpression of the multidrug resistance ( MDR 1) gene, which confers cross-resistance to hydrophobic natural product cytotoxic drugs. Expression of the MDR 1 gene can occur de novo in human cancers in the absence of drug treatment. The promoter of the human MDR 1 gene was shown to be a target for the c-Ha-Ras-1 oncogene and the p53 tumor suppressor gene products, both of which are associated with tumor progression. The stimulatory effect of c-Ha-Ras-1 was not specific for the MDR 1 promoter alone, whereas a mutant p53 specifically stimulated the MDR 1 promoter and wild-type p53 exerted specific repression. These results imply that the MDR 1 gene could be activated during tumor progression associated with mutations in Ras and p53.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Self-citationMutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
Endicott, J. A., & Ling, V. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.001033 · Cited by 2,071
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Molecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,637
Expression of a multidrug-resistance gene in human tumors and tissues.
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.265 · Cited by 1,544
Self-citationSelective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Gorman, C. M., Merlino, G. T., Willingham, M. C., Pastan, I., & Howard, B. H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.22.6777 · Cited by 1,298
Self-citationExpression of Multidrug Resistance Gene in Human Cancers
Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S.-L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., et al. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.2.116 · Cited by 1,290
Self-citationMonoclonal antibodies specific for simian virus 40 tumor antigens
Harlow, E., Crawford, L. V., Pim, D. C., & Williamson, N. M. (1981) · Journal of Virology · doi:10.1128/jvi.39.3.861-869.1981 · Cited by 1,039
Presence of a Potent Transcription Activating Sequence in the p53 Protein
Fields, S., & Jang, S. K. (1990) · Science · doi:10.1126/science.2144363 · Cited by 790
The multidrug transporter, a double-edged sword.
Gottesman, M. M., & Pastan, I. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37730-5 · Cited by 757
Self-citationMarshall, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90641-b · Cited by 751
Gannon, J. V., Greaves, R., Iggo, R., & Lane, D. P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08279.x · Cited by 688
Transcriptional Activation by Wild-Type but Not Transforming Mutants of the p53 Anti-Oncogene
Raycroft, L., Wu, H., & Lozano, G. (1990) · Science · doi:10.1126/science.2144364 · Cited by 619
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1989) · Journal of Histochemistry & Cytochemistry · doi:10.1177/37.2.2463300 · Cited by 604
Self-citationHinds, P. W., Finlay, C. A., Quartin, R. S., Baker, S. J., Fearon, E. R., Vogelstein, B., & Levine, A. J. (1990) · PubMed · Cited by 476
Rearrangement of the p53 gene in human osteogenic sarcomas.
Masuda, H., Miller, C., Koeffler, H. P., Battifora, H., & Cline, M. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7716 · Cited by 474
Chin, K. V., Tanaka, S., Darlington, G., Pastan, I., & Gottesman, M. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40219-6 · Cited by 393
Self-citationUeda, K., Pastan, I., & Gottesman, M. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45397-5 · Cited by 286
Self-citationExpression of the Multidrug-Resistant Gene in Hepatocarcinogenesis and Regenerating Rat Liver
Thorgeirsson, S. S., Huber, B. E., Sorrell, S., Fojo, A., Pastan, I., & Gottesman, M. M. (1987) · Science · doi:10.1126/science.3576227 · Cited by 273
Self-citationStanbridge, E. J. (1990) · Annual Review of Genetics · doi:10.1146/annurev.ge.24.120190.003151 · Cited by 259
p53 in chronic myelogenous leukemia in acute phase.
Feinstein, E., Cimino, G., Gale, R. P., Alimena, G., Berthier, R., Kishi, K., Goldman, J., Zaccaria, A., Berrebi, A., & Canaani, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6293 · Cited by 220
Ishii, S., Merlino, G. T., & Pastan, I. (1985) · Science · doi:10.1126/science.2999983 · Cited by 219
Self-citationPrimary Rat Embryo Cells Transformed by One or Two Oncogenes Show Different Metastatic Potentials
Pozzatti, R., Muschel, R., Williams, J., Padmanabhan, R., Howard, B., Liotta, L., & Khoury, G. (1986) · Science · doi:10.1126/science.3456644 · Cited by 196
Tumor suppressor genes: the p53 and retinoblastoma sensitivity genes and gene products
Levine, A. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(90)90015-s · Cited by 173
Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells.
Chin, K., Chauhan, S. S., Pastan, I. H., & Gottesman, M. M. (1990) · PubMed · Cited by 151
Self-citationAnalysis of human p53 proteins and mRNA levels in normal and transformed cells
Matlashewski, G., Banks, L., Pim, D., & Crawford, L. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09449.x · Cited by 139
Johnson, A., Ishii, S., Jinno, Y., Pastan, I. H., & Merlino, G. T. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60621-0 · Cited by 124
Self-citationGeiser, A. G., Kim, S. J., Roberts, A. B., & Sporn, M. B. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.1.84 · Cited by 124
Genetic basis of multidrug resistance of tumor cells
Kane, S. E., Pastan, I. H., & Gottesman, M. M. (1990) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf00762963 · Cited by 124
Self-citationArceci, R. J., Baas, F., Raponi, R., Horwitz, S. B., Housman, D. E., & Croop, J. M. (1990) · Molecular Reproduction and Development · doi:10.1002/mrd.1080250202 · Cited by 103
Quitschke, W. W., Lin, Z., DePonti-Zilli, L., & Paterson, B. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60565-4 · Cited by 88
Privalsky, M. L., Sharif, M., & Yamamoto, K. R. (1990) · Cell · doi:10.1016/0092-8674(90)90423-c · Cited by 75
Cited by
Clinical Implications of the p53 Tumor-Suppressor Gene
Harris, C. C., & Hollstein, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310283291807 · Cited by 1,330
mdm2 expression is induced by wild type p53 activity.
Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290
Mutant p53: one name, many proteins
Freed-Pastor, W. A., & Prives, C. (2012) · Genes & Development · doi:10.1101/gad.190678.112 · Cited by 1,247
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
Steffan, J. S., Kazantsev, A., Spasic-Boskovic, O., Greenwald, M., Zhu, Y.-Z., Gohler, H., Wanker, E. E., Bates, G. P., Housman, D. E., & Thompson, L. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100110097 · Cited by 1,062
Metadata
- Authors
- Chin, K.-V., Ueda, K., Pastan, I., & Gottesman, M. M.
- Venue
- Science
- Published
- 1992-01-24
- Volume
- 255
- Issue
- 5043
- Pages
- 459-462
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2076149108
- Cited by
- 726
- References
- 38
- FWCI
- 28.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.